Paricalcitol

Paricalcitol is a lipid of Sterol Lipids (ST) class. Paricalcitol is associated with abnormalities such as Vitamin D Deficiency. The involved functions are known as Hypertrophy, Left Ventricular. Paricalcitol often locates in Blood.

Cross Reference

Introduction

To understand associated biological information of Paricalcitol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Paricalcitol?

Paricalcitol is suspected in Vitamin D Deficiency and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with Paricalcitol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Paricalcitol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Paricalcitol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Paricalcitol?

There are no associated biomedical information in the current reference collection.

What genes are associated with Paricalcitol?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with Paricalcitol?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Paricalcitol

Download all related citations
Per page 10 20 50 100 | Total 375
Authors Title Published Journal PubMed Link
pmid:
Finch JL et al. Differential effects of 1,25-dihydroxy-vitamin D3 and 19-nor-1,25-dihydroxy-vitamin D2 on calcium and phosphorus resorption in bone. 1999 J. Am. Soc. Nephrol. pmid:10232683
Goldenberg MM Paricalcitol, a new agent for the management of secondary hyperparathyroidism in patients undergoing chronic renal dialysis. 1999 Clin Ther pmid:10321413
Zager RA Calcitriol directly sensitizes renal tubular cells to ATP-depletion- and iron-mediated attack. 1999 Am. J. Pathol. pmid:10362817
Stephens D et al. A statistical experimental approach to cosolvent formulation of a water-insoluble drug. 1999 Drug Dev Ind Pharm pmid:10434141
Chen TC et al. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer. 2000 Clin. Cancer Res. pmid:10741714
Balint E et al. Effect of the vitamin D analogues paricalcitol and calcitriol on bone mineral in vitro. 2000 Am. J. Kidney Dis. pmid:11007682
Brown AJ et al. Calcemic activity of 19-Nor-1,25(OH)(2)D(2) decreases with duration of treatment. 2000 J. Am. Soc. Nephrol. pmid:11053485
Shankar VN et al. In vitro metabolism of 19-nor-1alpha, 25-(OH)2D2 in cultured cell lines: inducible synthesis of lipid- and water-soluble metabolites. 2001 Arch. Biochem. Biophys. pmid:11370854
Finch JL et al. Relative potencies of 1,25-(OH)(2)D(3) and 19-Nor-1,25-(OH)(2)D(2) on inducing differentiation and markers of bone formation in MG-63 cells. 2001 J. Am. Soc. Nephrol. pmid:11423575